Asunto(s)
Infecciones por Helicobacter/epidemiología , Helicobacter pylori , Úlcera Péptica/epidemiología , Adulto , Antiinflamatorios no Esteroideos/efectos adversos , Antiinflamatorios no Esteroideos/uso terapéutico , Antirreumáticos/efectos adversos , Antirreumáticos/uso terapéutico , Artritis Reumatoide/tratamiento farmacológico , Aspirina/efectos adversos , Aspirina/uso terapéutico , Celecoxib , Niño , Método Doble Ciego , Femenino , Infecciones por Helicobacter/complicaciones , Humanos , Incidencia , Lactonas/efectos adversos , Lactonas/uso terapéutico , Masculino , Metaanálisis como Asunto , Osteoartritis/tratamiento farmacológico , Úlcera Péptica/inducido químicamente , Úlcera Péptica/etiología , Prevalencia , Pirazoles , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de Riesgo , Sulfonamidas/efectos adversos , Sulfonamidas/uso terapéutico , SulfonasRESUMEN
Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory bowel diseases (IBDs) of unknown origin. Current data suggest that the interaction of genetic, immunologic and environmental factors leads to chronic inflammation. In UC, the inflammation is limited to the mucosa whereas in CD, the whole bowel wall may be affected. The concept of genetic background is supported by the increased prevalence of CD within certain populations and individual families and by the results of twin studies. It is believed that not only the phenotype (CD or UC), but also the clinical course are influenced by genetic factors. It is unknown which trigger induces chronic immune stimulation. It could be either a nutritional antigen, a self antigen, a component of the normal gut flora or certain bacteria such a mycobacteria. The chronic immune stimulation may be due to a dysbalance of pro-inflammatory and inhibitory cytokines. Besides cytokines, a variety of different inflammatory mediators have a crucial role for the inflammatory process. Smoking has a significant effect on occurrence and outcome of CD and UC.
Asunto(s)
Colitis Ulcerosa/fisiopatología , Enfermedad de Crohn/fisiopatología , Animales , Colitis Ulcerosa/etiología , Colitis Ulcerosa/genética , Colitis Ulcerosa/inmunología , Enfermedad de Crohn/etiología , Enfermedad de Crohn/genética , Enfermedad de Crohn/inmunología , Citocinas/fisiología , Enfermedades en Gemelos/genética , Predisposición Genética a la Enfermedad , Humanos , Mediadores de Inflamación/fisiología , Interleucinas/fisiología , Ratones , Fenotipo , Fumar , Factor de Necrosis Tumoral alfa/fisiologíaRESUMEN
BACKGROUND AND AIMS: The main goal of our study was to characterise the activity of BIM26226 as a peripheral gastrin releasing peptide (GRP) receptor antagonist in healthy human subjects and to determine if endogenous GRP is a physiological regulator of gastric acid secretion and gastrin release. METHODS: Our study consisted of three parts. In part I, subjects received saline or BIM26226 followed by graded doses of intravenous human GRP in a four period crossover design. In part II, subjects received BIM26226 or saline during oral meal ingestion or modified sham feeding. In part III, subjects received an acidified meal in the presence and absence of BIM26226 in a two period crossover design. In addition, gastrin and somatostatin mRNA were measured in biopsy specimens during saline and BIM26226 infusion. RESULTS: BIM26226 dose dependently inhibited GRP induced acid output. Acid secretion after oral liquid meal intake and sham feeding was significantly inhibited by BIM26226 (p<0.01) whereas plasma gastrin release remained unchanged. Gastrin and somatostatin mRNAs were not significantly different after saline or BIM26226. CONCLUSIONS: BIM26226 is a potent GRP antagonist in humans. Endogenous GRP may be a physiological regulator of gastric acid secretion. Gastrin release does not seem to be under the control of GRP.
Asunto(s)
Bombesina/análogos & derivados , Bombesina/farmacología , Ácido Gástrico/metabolismo , Péptido Liberador de Gastrina/fisiología , Fragmentos de Péptidos/farmacología , Adulto , Análisis de Varianza , Northern Blotting , Estudios Cruzados , Relación Dosis-Respuesta a Droga , Método Doble Ciego , Ingestión de Alimentos/fisiología , Determinación de la Acidez Gástrica , Péptido Liberador de Gastrina/antagonistas & inhibidores , Gastrinas/análisis , Humanos , Masculino , Persona de Mediana Edad , ARN Mensajero/análisis , Somatostatina/análisis , Estadísticas no ParamétricasRESUMEN
We retrospectively studied 42 liver biopsy specimens from 39 patients who met serologic and histologic criteria of autoimmune liver diseases. We found 10 cases of overlap syndrome (OLS), 10 autoimmune cholangitis (AIC), 10 primary biliary cirrhosis (PBC), and 9 autoimmune hepatitis (AIH) type 1. The following results were obtained: (1) Granulomas and biliary duct lesions were more prominent in PBC and AIC than in OLS and AIH. (2) Bile duct loss was not observed in AIH cases. (3) Features of hepatocellular damage such as piecemeal necrosis, spotty lobular necrosis, and confluent necrosis, were much more prevalent in OLS and AIH than in PBC and AIC. (4) HLA-DR antigen expression by hepatocytes was more frequent in AIH and OLS, whereas the expression of the same antigen by the bile duct epithelium was more frequent in PBC and AIC. We conclude there is a morphologic spectrum in autoimmune liver diseases, in which PBC forms one end of the spectrum, AIH the other, OLS the middle but closer clinically and histologically to AIH than to PBC, and AIC, which seems to be an antimitochondrial antibody-negative subtype of PBC.
Asunto(s)
Enfermedades Autoinmunes/patología , Hepatopatías/inmunología , Adulto , Anciano , Conductos Biliares/inmunología , Conductos Biliares/patología , Biopsia , Colangitis/inmunología , Colangitis/patología , Femenino , Granuloma/inmunología , Granuloma/patología , Antígenos HLA-DR/análisis , Hepatitis Autoinmune/patología , Humanos , Hígado/inmunología , Hígado/patología , Cirrosis Hepática Biliar/inmunología , Cirrosis Hepática Biliar/patología , Masculino , Persona de Mediana Edad , Necrosis , Estudios RetrospectivosRESUMEN
To study the usefulness of calretinin as an immunohistochemistry marker in the diagnosis of cardiac myxoma (CM) and the origin of myxoma cells, we examined 24 CMs and 9 fetal hearts with immunohistochemical methods on formalin-fixed paraffin-embedded tissues. We compared 24 CMs with 10 mural thrombi, 6 jaw myxomas, and 2 papillary fibroelastomas. Calretinin expression was identified in 100% of CMs and was negative in all cases of mural thrombi, jaw myxoma, and papillary fibroelastoma. Calretinin expression by the neoplastic cells in CM was strong and diffuse and had a cytoplasmic and a nuclear pattern. Calretinin expression in fetal hearts was found in autonomic ganglia cells in the subepicardial tissue of the atria and atrial appendages, along the interatrial and atrioventricular sulci, and in the atrial septum. Results clearly indicate that calretinin can be used as a marker for the diagnosis of CM and that it is a powerful tool for the differential diagnosis, most importantly with mural myxoid thrombi. Furthermore, the positive expression of calretinin by the autonomic neurons in the fetal heart and CM supports the concept that myxoma cells may originate from endocardial sensory nerve tissue.
Asunto(s)
Biomarcadores de Tumor/análisis , Neoplasias Cardíacas/química , Mixoma/química , Proteína G de Unión al Calcio S100/análisis , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Azul Alcián , Vasos Sanguíneos/patología , Calbindina 2 , Núcleo Celular/patología , Cromatina/patología , Femenino , Corazón/embriología , Neoplasias Cardíacas/patología , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Miocardio/química , Mixoma/patología , Reacción del Ácido Peryódico de Schiff , Sensibilidad y EspecificidadRESUMEN
BACKGROUND/AIMS: Helicobacter pylori is considered to be the primary cause of most forms of gastritis, but its role as a causative agent in gastric erosions is unclear. The aim of this study was to estimate the prevalence of gastric erosions and H. pylori infection in asymptomatic volunteers. METHODS: 175 asymptomatic subjects underwent upper gastrointestinal endoscopy. Antral biopsies were taken for bacterial cultures, histology and quick urease (CLO) test. A (13)C-urea breath test was performed after endoscopy. NSAID intake, alcohol consumption and smoking habits were also recorded in each subject. RESULTS: 33 (19%) of 175 asymptomatic volunteers had macroscopic lesions on upper gastrointestinal endoscopy, 7 were H. pylori positive, 26 were H. pylori negative. Gastric erosions occurred in 8% (14 subjects) of all volunteers. 10 subjects were H. pylori negative and 4 H. pylori positive. In 11 volunteers, gastric erosions were restricted to the prepyloric antrum. Only 1 of 14 subjects had a history of NSAID intake and 6 subjects were alcohol abstainers. CONCLUSION: We conclude that gastric erosions occur in a considerable amount of asymptomatic volunteers. They are predominantly localized in the prepyloric antrum and are most likely not associated with H. pylori infection, NSAID intake, smoking or alcohol consumption.
Asunto(s)
Infecciones por Helicobacter/complicaciones , Helicobacter pylori/patogenicidad , Estómago/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Consumo de Bebidas Alcohólicas/efectos adversos , Antiinflamatorios no Esteroideos/efectos adversos , Endoscopía Gastrointestinal , Femenino , Humanos , Mucosa Intestinal/microbiología , Mucosa Intestinal/patología , Masculino , Persona de Mediana Edad , Estómago/microbiologíaRESUMEN
H. pylori is the cause of one of the most common infectious diseases worldwide. Infection with H. pylori leads to exaggerated synthesis of several inflammatory cytokines. Only a minority of infected patients develops peptic ulcer disease. H. pylori strains associated with peptic ulcer disease induce strong mucosal infiltration with inflammatory cells and increased expression of several cytokines. Cytokines may contribute to ulcer development by different mechanisms, including stimulation of gastrin and pepsinogen release, suppression of somatostatin synthesis and activation of inflammatory cells.
Asunto(s)
Citocinas/fisiología , Infecciones por Helicobacter/fisiopatología , Helicobacter pylori , Úlcera Péptica/fisiopatología , Infecciones por Helicobacter/diagnóstico , Humanos , Mediadores de Inflamación/fisiologíaRESUMEN
BACKGROUND: Clarithromycin and nitroimidazoles such as metronidazole and ornidazole are among the most frequently used antibiotics for curing Helicobacter pylori infection. However, controversial data exist on whether their in vitro resistance has a negative impact on treatment outcome. METHODS: Patients with H. pylori positive active peptic ulcer disease were randomly assigned to receive lansoprazole 30 mg o.d., amoxycillin 1 g b.d. and ornidazole 500 mg b.d. (LAO) or lansoprazole 30 mg o.d., amoxycillin 1 g b.d. and clarithromycin 500 mg b.d. (LAC) for 2 weeks. Pre-treatment resistance to ornidazole and clarithromycin was assessed by Epsilometer (E-) test. Four weeks after completion of treatment, patients underwent a 13C urea breath test to assess H. pylori status. RESULTS: Data from 80 patients with active peptic ulcer disease and positive H. pylori status were analysed. The prevalence of primary drug resistance was 25% for metronidazole and 7.5% for clarithromycin. In patients treated with LAO, effective treatment was achieved in 87% of metronidazole-susceptible, but only 30% of metronidazole-resistant strains (P < 0.01). In the LAC group, therapy was successful in 81% of clarithromycin-susceptible strains, whereas treatment failed in all patients with primary clarithromycin resistance (n = 3). CONCLUSION: Resistance against nitroimidazoles significantly affects treatment outcome in H. pylori eradication therapy.
Asunto(s)
Antibacterianos/uso terapéutico , Claritromicina/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori , Ornidazol/uso terapéutico , Úlcera Péptica/tratamiento farmacológico , 2-Piridinilmetilsulfinilbencimidazoles , Adolescente , Adulto , Anciano , Amoxicilina/uso terapéutico , Antiulcerosos/uso terapéutico , Combinación de Medicamentos , Farmacorresistencia Microbiana , Endoscopía Gastrointestinal , Femenino , Infecciones por Helicobacter/microbiología , Humanos , Lansoprazol , Masculino , Persona de Mediana Edad , Omeprazol/análogos & derivados , Omeprazol/uso terapéutico , Penicilinas/uso terapéutico , Úlcera Péptica/microbiología , Resultado del TratamientoRESUMEN
We report the unique case of a 52-year-old patient with atypical morphological features of gastric Langerhans cell histiocytosis. The man was admitted because of increasing upper abdominal pain and weight loss. The upper gastrointestinal endoscopy showed a submucous, hemispherical tumor of the stomach wall along the lesser curvature. The tumor was completely removed and the patient was discharged 11 days later. Two months later, he died at home. The cause of death is unknown, because the autopsy was denied by the relatives. Macroscopically, the stomach showed a 4.5 x 2.5 cm large, spherical tumor of the lesser curvature of the corpus, which infiltrated the perigastric omenta and lymph nodes, the distal pancreas and the glissonian liver capsule. The vast majority of neoplastic cells were intensely positive for S-100 and CD1a. Typical Birbeck granules could be identified in almost all cells. Cell nuclei analyzed by flow cytometry showed an aneuploid peak, a feature typically associated with malignant disease.
Asunto(s)
Histiocitosis de Células de Langerhans/patología , Gastropatías/patología , Estómago/patología , Gránulos Citoplasmáticos/ultraestructura , Resultado Fatal , Citometría de Flujo , Gastroscopía , Histiocitosis de Células de Langerhans/cirugía , Humanos , Células de Langerhans/ultraestructura , Masculino , Persona de Mediana Edad , Gastropatías/cirugía , Tomografía Computarizada por Rayos XRESUMEN
The administration of nonsteroidal anti-inflammatory drugs (NSAIDs) is frequently associated with injury to the gastroduodenal mucosa and leads in approximately 1.5% of patients to severe complications such as haemorrhage or perforation. The risk of serious upper GI complications is increased in patients > 65 years with a previous history of peptic ulcer disease or gastrointestinal haemorrhage, concomitant steroid use and significant cardiovascular comorbidity. Previous studies have shown that misoprostol is effective in reducing the incidence of gastric and duodenal ulcers as well as serious gastrointestinal complications. Recently, four large clinical trials have demonstrated that omeprazole is effective in preventing and treating NSAID-induced ulcers. Omeprazole when compared to misoprostol was equally effective in preventing gastric ulcers and more effective in duodenal ulcers. For treatment of gastric and duodenal ulcers, omeprazole was more effective than misoprostol and ranitidin. Prophylaxis of NSAID-induced ulcers should be administered in all patients with several risk factors for serious gastrointestinal complications.
Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Antiulcerosos/uso terapéutico , Úlcera Duodenal/inducido químicamente , Úlcera Gástrica/inducido químicamente , Ensayos Clínicos como Asunto , Úlcera Duodenal/tratamiento farmacológico , Úlcera Duodenal/prevención & control , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/patología , Humanos , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/patología , Misoprostol/uso terapéutico , Omeprazol/uso terapéutico , Factores de Riesgo , Úlcera Gástrica/tratamiento farmacológico , Úlcera Gástrica/prevención & controlRESUMEN
Diffuse liver hemangiomatosis is extremely rare. The etiology and natural history of the disease are unknown. It is also unclear whether tumor growth is induced or modulated by drug therapy. Tumor recurrence after ablative therapy has not been described in patients with diffuse liver hemangiomatosis. Diffuse hemangiomatosis of the left hepatic lobe was suspected in a 35-year-old woman by ultrasonography, CT and hepatic arteriography, and confirmed by laparotomy and biopsies. The patient denied any drug or estrogen use. The tumor was removed by left hepatectomy. Two and six years later, the patient was again hospitalized with progressive tumor growth into the right hepatic lobe. Although diffuse liver hemangiomatosis is a rare disease, its diagnosis should be considered in patients with progressive tumor growth in one or both hepatic lobes. The absence of drug intake or estrogen use does not exclude the diagnosis.
Asunto(s)
Hemangioma/fisiopatología , Neoplasias Hepáticas/fisiopatología , Adulto , Angiografía , Biopsia , Femenino , Hemangioma/diagnóstico , Hemangioma/cirugía , Hepatectomía , Humanos , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/cirugía , Recurrencia , Tomografía Computarizada por Rayos XRESUMEN
Restitution, the lateral migration of cells over an intact basement membrane, maintains mucosal integrity. We studied the regulation of migration and proliferation of enzyme-dispersed canine oxyntic mucosa cells in primary culture. Confluent monolayers were wounded and cultured in serum-free medium, and cells migrating into the wound were counted. [3H]thymidine incorporation into DNA was studied using subconfluent cultures. Considerable migration occurred in untreated monolayers; however, epidermal growth factor (EGF), transforming growth factor (TGF)-alpha, basic fibroblast growth factor (bFGF), insulin-like growth factor I (IGF-I), two trefoil peptides, and interleukin (IL)-1beta further enhanced migration. The specific EGF receptor (EGFR) monoclonal antibody, MAb-528, inhibited both basal and TGF-alpha- or IL-1beta-stimulated migration, but not the response to trefoil peptide, bFGF, or IGF-I. Exogenous TGF-beta inhibited cell proliferation but did not alter migration. Immunoneutralization with anti-TGF-beta blocked the response to exogenous TGF-beta and produced a small enhancement of basal thymidine incorporation but did not attenuate basal or TGF-alpha-stimulated migration. In conclusion, endogenous EGFR ligands regulate proliferation and migration. TGF-beta inhibits mitogenesis; it did not upregulate migration in these cultures. Although bFGF, IGF-I, and IL-1beta enhance gastric epithelial migration, only IL-1beta acted in a TGF-alpha-dependent fashion.
Asunto(s)
División Celular/efectos de los fármacos , Movimiento Celular/efectos de los fármacos , Sustancias de Crecimiento/farmacología , Mucinas , Proteínas Musculares , Neuropéptidos , Células Parietales Gástricas/citología , Células Parietales Gástricas/efectos de los fármacos , Animales , Citocinas/farmacología , ADN/biosíntesis , Perros , Factor de Crecimiento Epidérmico/farmacología , Receptores ErbB/fisiología , Factor 2 de Crecimiento de Fibroblastos/farmacología , Glicosilación , Factor I del Crecimiento Similar a la Insulina/farmacología , Péptidos y Proteínas de Señalización Intercelular , Ligandos , Péptidos/farmacología , Proteínas Recombinantes/farmacología , Factor de Crecimiento Transformador alfa/farmacología , Factor Trefoil-2 , Factor Trefoil-3RESUMEN
Cerebral ischemia and symptoms of stroke can occur as a rare manifestation in patients with pheochromocytoma. We describe a 45-year-old woman who was admitted because of a right-sided hemiparesis due to an ischemic lesion in the left hypothalamus. The clinical diagnosis of a pheochromocytoma was proven by highly elevated urinary catecholamines and confirmed histologically after operation. The successful removal of the tumor led to the almost complete recovery of the neurological deficiencies. It is of vital importance to know this atypical presentation of pheochromocytoma. The diagnosis of pheochromocytoma should be suspected in patients with focal cerebral symptoms, particularly in the presence of intermittent hypertension or other paroxysmal symptoms suggestive of pheochromocytoma.
Asunto(s)
Neoplasias de las Glándulas Suprarrenales/complicaciones , Isquemia Encefálica/etiología , Feocromocitoma/complicaciones , Neoplasias de las Glándulas Suprarrenales/diagnóstico , Neoplasias de las Glándulas Suprarrenales/cirugía , Isquemia Encefálica/terapia , Catecolaminas/orina , Femenino , Hemiplejía/etiología , Humanos , Hipotálamo/irrigación sanguínea , Persona de Mediana Edad , Feocromocitoma/diagnóstico , Feocromocitoma/cirugía , Tomografía Computarizada por Rayos XRESUMEN
Helicobacter pylori is the cause of chronic type B gastritis and occurs in almost all patients with duodenal ulcers. Infection with H. pylori is characterized by an increased production of several inflammatory cytokines. Increasing evidence suggests a central role of these cytokines in the pathogenesis of H. pylori-associated gastritis and peptic ulcer disease. Cytokines may be crucial in the recruitment and activation of inflammatory cells and in stimulation of gastrin release. In addition to their proinflammatory properties, cytokines may also inhibit the ulcer occurrence by stimulation of prostaglandins and somatostatin release and by direct impairment of acid secretion. The balance of these factors may determine the clinical outcome of H. pylori infection.
Asunto(s)
Citocinas/fisiología , Úlcera Péptica/inmunología , Úlcera Péptica/fisiopatología , Animales , Úlcera Duodenal/inmunología , Úlcera Duodenal/fisiopatología , Gastrinas/fisiología , Gastritis/inmunología , Gastritis/microbiología , Gastritis/fisiopatología , Genes MHC Clase II , Infecciones por Helicobacter/inmunología , Infecciones por Helicobacter/fisiopatología , Helicobacter pylori , Humanos , Inflamación , Mucosa Intestinal/inmunología , Mucosa Intestinal/fisiopatología , Somatostatina/fisiologíaRESUMEN
Patients chronically infected with Helicobacter pylori are known to have hypergastrinemia. Previous studies have demonstrated the stimulation of gastrin from isolated G cells by monocytes and cytokines. The aim of this study was to determine if H. pylori can directly stimulate gastrin secretion. The secretion of gastrin from canine G cells in 48-h primary cultures was investigated using either live H. pylori bacteria or various bacterial extracts from three well-characterized strains. Whole bacterial sonic extracts and water-extracted surface proteins, but not PBS extracts, from strains 43579 (CagA+/VacA+), 60190 (CagA+/VacA+), and 60190:v1 (CagA+/VacA-) significantly stimulated gastrin release. Controls demonstrated that gastrin stimulation by the sonic extracts was not due to a direct toxic effect on G cells. We conclude that H. pylori produces a soluble factor(s), which can directly stimulate gastrin release in enriched canine G cell cultures. This stimulatory effect may play an important role in the H. pylori-associated hypergastrinemia and subsequent development of peptic ulcer disease.
Asunto(s)
Gastrinas/metabolismo , Helicobacter pylori/fisiología , Antro Pilórico/metabolismo , Antro Pilórico/microbiología , Animales , Proteínas Bacterianas/farmacología , Células Cultivadas , Perros , SonicaciónRESUMEN
Helicobacter pylori infected patients have increased gastrin release which shows a marked fall after cure of the infection. Recent studies indicate that inflammatory cells and cytokines play an important role in the pathogenesis of Helicobacter-associated hypergastrinemia. Views differ regarding the impact of gastrin on acid secretion. Current evidence suggests that gastrin is responsible for at least some of the increased acid secretion seen in duodenal ulcer patients.
Asunto(s)
Úlcera Duodenal/metabolismo , Gastrinas/fisiología , Infecciones por Helicobacter/metabolismo , Helicobacter pylori , Ácido Gástrico/metabolismo , Gastrinas/sangre , Infecciones por Helicobacter/microbiología , Humanos , Somatostatina/fisiologíaRESUMEN
Patients with Helicobacter pylori-associated gastritis have an increased release of gastrin. The mechanisms by which H. pylori affects the endocrine cells are unclear. We have used primary cultures containing canine antral G cells to examine the effects of human blood mononuclear cells, purified monocytes and lymphocytes, recombinant cytokines, and NH4Cl on gastrin release. Mononuclear cells and purified monocytes in direct contact with G cells stimulated gastrin release dose dependently. Separating mononuclear cells from G cells by Transwell filters with 0.4-micron pore size still produced a significant increase of gastrin release. Three human recombinant cytokines, interferon-gamma, tumor necrosis factor-alpha, and interleukin-2, but not interleukin-6 and interleukin-1 beta, each produced dose-dependent increases of gastrin stimulation. NH4Cl did not stimulate gastrin release. We conclude that mononuclear cells and purified monocytes prepared from human blood, as well as several cytokines, stimulate gastrin release from antral G cells. These factors may play an important role in the pathogenesis of H. pylori-associated hypergastrinemia.